King’s College London

Developer of a legal technology platform designed to assist law practitioners. The company's platform utilizes artificial intelligence for task execution, automated legal research with precise citations, and contract interpretation, and offers secure collaboration tools, enabling law firms to streamline workflows, enhance accuracy, and focus on complex reasoning while minimizing time spent on routine paperwork.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.